Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
TAFAZZIN - Tafazzin, Phospholipid-lysophospholipid Transacylase
Alias:
EFE
TAZ
BTHS
EFE2
G4.5
Taz1
CMD3A
LVNCX
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因编码的蛋白质在心脏和骨骼肌中表达水平很高。这个基因的突变与许多临床病症有关,包括巴特综合征、扩张性心肌病(DCM)、肥厚性DCM、心内膜弹性纤维症和左心室非紧凑(LVNC)。已经描述了多种编码不同异型体的转录变异体。这些异型体的长形式和短形式都产生了;短形式缺乏疏水前导序列,可能作为细胞质蛋白存在而不是膜结合。已经描述了其他可选的剪接转录本,但所有这些转录本的全长度尚未可知。[由RefSeq,2008年7月提供]
Related ID:
NCBI:6901
ENSEMBL:ENSG00000102125
HGNC:11577
UNIPROT:Q16635
OMIM:300394
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
6901
16
11
10188 bp
30.20
387
3
5
20
TAFAZZIN Genetics information (+)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top